Devgen (Euronext, Brussels: DEVG) - Disclosure in accordance with the Transparency Legislation of May 2, 2007

Regulated Information Gent (Belgium) - May 19, 2009 - According to Article 14 of the Law of May 2, 2007 on the disclosure of major shareholdings in listed companies, Devgen nv hereby informs that it received the following notification of shareholding: +-------------------------------------------------------------------+ | | | Number of | Number of | | | | | voting rights | voting | % | | | Denominator | before the | rights after | voting | | | | transaction | the | rights | | | | | transaction | | |------------+-------------+----------------+--------------+--------| | KBC Asset | | | | | | Management | 17,891,734 | 558,863 | Not declared | <3 % | | NV | | | | | +-------------------------------------------------------------------+ The transaction is dated 30 April, 2009. About Devgen Devgen's mission is to enable farmers to sustainably grow more food on less land, with less water, agrochemicals and labor. Devgen uses advanced biotechnology and molecular breeding technology to make high yielding seeds and crop protection solutions with a superior environmental profile. Devgen brings this technology to the market in the world's major food and feed crops through two complementary strategies: - Licensing Devgen technology for use in corn, cotton and soy and selected other crops in exchange for R&D funding, and milestone and royalty payments. - Producing and selling its premium hybrid seeds in major field crops such as rice, sunflower, sorghum, and pearl millet, in the Indian subcontinent and S.E. Asia. In its Crop Protection unit, Devgen develops a novel nematicide, an agro-chemical product that protects crops from damage by parasitic nematodes. Incorporated in 1997, Devgen has offices in Ghent (Belgium), Singapore, Hyderabad (India) and Delaware (US) and employs more than 200 people. For more information please contact: Thierry Bogaert, CEO Wim Goemaere, CFO Tel. +32 9 324.24.24 Tel. +32 9324.24.24 or visit: This press release may contain forward-looking statements containing the words "anticipates", "expects" , "intends", "plans", "estimates", "may" and "continues" as well as similar expressions. Such forward looking statements may involve known and unknown risks, uncertainties and other factors which might cause the actual results, performance or achievements of Devgen to be materially different from any future results or achievements expressed or implied by such forward-looking statements. These forward looking statements speak only as of the date of publication of this document. Devgen disclaims any obligation to update such forward looking statements in this document to reflect any change in its expectations, conditions or circumstances on which such statement is based, unless required by law or regulation. This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.